Biblio

Export 57 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Positron-Emission Tomography  [Clear All Filters]
2023
J. Jia, Zhang, Y., Shi, Y., Yin, X., Wang, S., Li, Y., Zhao, T., Liu, W., Zhou, A., and Jia, L., A 19-Year-Old Adolescent with Probable Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 3, pp. 915-922, 2023.
C. Gonzalez, Mimmack, K. J., Amariglio, R. E., J Becker, A., Chhatwal, J. P., Fitzpatrick, C. D., Gatchel, J. R., Johnson, K. A., Katz, Z. S., Kuppe, M. K., Locascio, J. J., Udeogu, O. J., Papp, K. V., Premnath, P., Properzi, M. J., Rentz, D. M., Schultz, A. P., Sperling, R. A., Vannini, P., Wang, S., and Marshall, G. A., Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings., J Alzheimers Dis, vol. 94, no. 1, pp. 217-226, 2023.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
2018
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset., J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
P. J. Lao, Handen, B. L., Betthauser, T. J., Mihaila, I., Hartley, S. L., Cohen, A. D., Tudorascu, D. L., Bulova, P. D., Lopresti, B. J., Tumuluru, R. V., Murali, D., Mathis, C. A., Barnhart, T. E., Stone, C. K., Price, J. C., Devenny, D. A., Johnson, S. C., Klunk, W. E., and Christian, B. T., Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome., J Alzheimers Dis, vol. 61, no. 2, pp. 631-644, 2018.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40., J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.
I. Piaceri, Bessi, V., Matà, S., Polito, C., Tedde, A., Berti, V., Bagnoli, S., Braccia, A., Del Mastio, M., Pignone, A. Moggi, Pupi, A., Sorbi, S., and Nacmias, B., Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline., J Alzheimers Dis, vol. 61, no. 1, pp. 41-46, 2018.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N., Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β., J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
I. Álvarez, Aguilar, M., González, J. Manuel, Ysamat, M., Lorenzo-Bosquet, C., Alonso, A., Tartari, J. Pablo, Romero, S., Diez-Fairen, M., Carcel, M., Pujalte, F., and Pastor, P., Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia., J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
J. A. Matías-Guiu, Cabrera-Martín, M. Nieves, Curiel, R. E., Valles-Salgado, M., Rognoni, T., Moreno-Ramos, T., Carreras, J. Luis, Loewenstein, D. A., and Matías-Guiu, J., Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms., J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
D. W. Scharre, Weichart, E., Nielson, D., Zhang, J., Agrawal, P., Sederberg, P. B., Knopp, M. V., and Rezai, A. R., Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 621-633, 2018.
K. Nakaizumi, Ouchi, Y., Terada, T., Yoshikawa, E., Kakimoto, A., Isobe, T., Bunai, T., Yokokura, M., Suzuki, K., and Magata, Y., In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
A. Ishikawa, Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., Ji, B., Zhang, M. - R., Aoki, I., Suhara, T., Higuchi, M., and Sahara, N., In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510., J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
C. M. Burns, Kaszniak, A. W., Chen, K., Lee, W., Bandy, D. J., Caselli, R. J., and Reiman, E. M., Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions., J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.
C. Lange, Suppa, P., Pietrzyk, U., Makowski, M. R., Spies, L., Peters, O., and Buchert, R., Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status., J Alzheimers Dis, vol. 61, no. 1, pp. 373-388, 2018.
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S., Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
C. - C. Tan, Zhang, X. - Y., Tan, L., and Yu, J. - T., Tauopathies: Mechanisms and Therapeutic Strategies., J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.

Pages